Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan - Zhao, Tianchen; Tani, Yuta; Makino-Okamura, Chieko; Takita, Morihito; Yamamoto, Chika; Kawahara, Eiki; Abe, Toshiki; Sugiura, Sota; Yoshimura, Hiroki; Uchiyama, Taiga; Yamazaki, Isato; Ishigame, Harumichi; et al. (Frontiers in immunology, 2024)
Keywords: antibody waning; bivalent vaccination; Immunology; mRNA vaccination vulnerable population; SARS-CoV2; vaccination; bivalent vaccination; SARS-CoV2; antibody waning; mRNA vaccination vulnerable population; vaccination